Trial Profile
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Aug 2023
Price :
$35
*
At a glance
- Drugs Maraviroc (Primary)
- Indications HIV infections; Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 26 Jul 2022 Status changed from active, no longer recruiting to completed.
- 25 May 2022 Planned primary completion date changed from 1 Apr 2022 to 1 May 2022.
- 03 Nov 2021 Planned primary completion date changed from 1 Apr 2021 to 1 Apr 2022.